This week in drug discovery (20-24 June)

News round-up by DDW’s Reece Armstrong for 20-24 June.

Covid-19 vaccine development and research, gene therapies for dementia and a ‘game-changing’ treatment for HIV are some of the themes of this week’s news round-up.

Moderna to set up mRNA vaccine centre in UK 

Pharmaceutical company Moderna is to set-up a manufacturing and research development centre in the UK following an agreement with the government.

Researchers target one-time treatment for HIV 

A one-time treatment for HIV and AIDS may be possible thanks to gene editing, according to research conducted by scientists from Tel Aviv University (TAU).

Collaboration to develop African-owned Covid-19 vaccine 

A collaboration between two biotech companies hopes to pave the way for the development of the first-ever African-owned Covid-19 vaccine.

New partnership looks to gene therapy for dementia  

The Cell and Gene Therapy Catapult (CGT Catapult) has partnered with the UK Dementia Research Institute (UK DRI) to help advance the development of adeno-associated virus (AAV) based gene therapies for dementia.

Pistoia Alliance appoints first female president  

The Pistoia Alliance has appointed its first female President with Dr Becky Upton taking on the position, the organisation has announced.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free